1. Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo‐refractory germ cell tumors. (23rd April 2022) Authors: Kawahara, Takashi; Kawai, Koji; Kojima, Takahiro; Nagumo, Yoshiyuki; Sakka, Shotarou; Kandori, Shuya; Negoro, Hiromitsu; Mathis, Bryan J; Maruo, Kazushi; Miura, Koji; Sakamoto, Noriaki; Shinohara, Nobuo; Yamashita, Shinichi; Yonemori, Kan; Kishida, Takeshi; Ukimura, Osamu; Nishimura, Kazuo; Kobay... Journal: International journal of urology Issue: Volume 29:Number 7(2022) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗